Literature DB >> 24389932

[Mild whole body hyperthermia in combination with inpatient multimodal oriented pain therapy: evaluation in patients with chronic unspecific lumbar back pain].

U Ettrich1, B Konrad, K Prate, J Seifert, F Krummenauer.   

Abstract

PURPOSE: A randomized controlled clinical trial was implemented to evaluate the effectiveness of combined mild hyperthermia therapy (body core temperature 38.4 °C) and multimodal inpatient rehabilitation for patients suffering from chronic low back pain when compared to multimodal pain therapy alone. PATIENTS AND METHODS: A total of 88 patients were randomly assigned to the combined or single therapeutic schemes according to a block randomization scheme. According to the trial inclusion criteria all patients suffered from chronic low back pain and showed morphological degeneration. All patients underwent a 12-day inpatient multimodal pain therapy, which was complemented with a 6-session schedule of mild hyperthermia therapy for the intervention group (1 h at 38.6 °C). On admission and 3 months after treatment the study patients were asked to complete an interview assessment with the Oswestry low back pain disability questionnaire (Oswestry disability index). The change in the Oswestry disability index total score (%) 3 months after versus before therapy was defined as the primary clinical endpoint of the investigation. The patients in the control group and in the intervention group had a median age of 50 years. In the intervention group 70 % of the patients were female and 55 % reported having half to full time employment compared to 55 % and 43 % in the control group, respectively.
RESULTS: On admission the control patients reported a median Oswestry disability index of 64 % and on recall the same of 64 %. The intervention group showed median Oswestry disability index estimates of 60 % and 66 %, respectively. The changes in the overall Oswestry disability index after 3 months differed significantly with an estimated 6 % for the intervention group versus 0 % for the control group (Wilcoxon p = 0.050).
CONCLUSION: When combined with a multimodal inpatient lower back pain functional therapy in patients showing morphological degeneration, the mild hyperthermia therapy demonstrated statistically significant, although not clinically relevant benefits in comparison to the multimodal treatment alone. However, regarding the moderate overall patient-related benefits as measured in terms of the Oswestry disability index, the benefit of the underlying multimodal therapy concept implementation must be critically discussed irrespective of its combination with mild hyperthermia therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24389932     DOI: 10.1007/s00132-013-2180-3

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  16 in total

Review 1.  Functional restoration programs for low back pain: a systematic review.

Authors:  S Poiraudeau; F Rannou; M Revel
Journal:  Ann Readapt Med Phys       Date:  2007-04-25

2.  [Multimodal therapy--who profits?: chances and risks of predicting treatment success].

Authors:  A Becker
Journal:  Schmerz       Date:  2011-06       Impact factor: 1.107

3.  [Measures of success in treatment of chronic back pain: pain intensity, disability and functional capacity: determinants of treatment success in multimodal day clinic setting].

Authors:  M Heinrich; K Hafenbrack; C Michel; D Monstadt; U Marnitz; R Klinger
Journal:  Schmerz       Date:  2011-06       Impact factor: 1.107

Review 4.  Evidence-informed management of chronic low back pain with cognitive behavioral therapy.

Authors:  Robert J Gatchel; Kathryn H Rollings
Journal:  Spine J       Date:  2008 Jan-Feb       Impact factor: 4.166

5.  Costs of back pain in Germany.

Authors:  Christina M Wenig; Carsten O Schmidt; Thomas Kohlmann; Bernd Schweikert
Journal:  Eur J Pain       Date:  2008-06-03       Impact factor: 3.931

6.  [Evaluation of a multimodal pain therapy at the University Pain Centre Dresden].

Authors:  A Schütze; U Kaiser; U Ettrich; K Grosse; G Gossrau; M Schiller; K Pöhlmann; K Brannasch; R Scharnagel; R Sabatowski
Journal:  Schmerz       Date:  2009-12       Impact factor: 1.107

7.  [Risk assessment in pain therapy].

Authors:  D Schoeffel; H R Casser; M Bach; H G Kress; R Likar; H Locher; W Steinleitner; M Strohmeier; H Brunner; R D Treede; W Zieglgänsberger; J Sandkühler
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

Review 8.  [Multimodal pain therapy: principles and indications].

Authors:  B Arnold; T Brinkschmidt; H-R Casser; I Gralow; D Irnich; K Klimczyk; G Müller; B Nagel; M Pfingsten; M Schiltenwolf; R Sittl; W Söllner
Journal:  Schmerz       Date:  2009-04       Impact factor: 1.107

9.  [Multidisciplinary treatment program for chronic low back pain, part 2. Somatic aspects].

Authors:  P Saur; J Hildebrandt; M Pfingsten; D Seeger; U Steinmetz; A Straub; J Hahn; B Kasi; R Heinemann; D Koch
Journal:  Schmerz       Date:  1996-10-28       Impact factor: 1.107

10.  [Multidisciplinary treatment program on chronic low back pain, part 4. Prognosis of treatment outcome and final conclusions].

Authors:  M Pfingsten; J Hildebrandt; P Saur; C Franz; D Seeger
Journal:  Schmerz       Date:  1997-02-25       Impact factor: 1.107

View more
  1 in total

1.  Fibromyalgia with severe forms of progression in a multidisciplinary therapy setting with emphasis on hyperthermia therapy--a prospective controlled study.

Authors:  Tobias Romeyke; Hans Christoph Scheuer; Harald Stummer
Journal:  Clin Interv Aging       Date:  2014-12-19       Impact factor: 4.458

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.